ALAMEDA, Calif-Calypte Biomedical Corporation has announced the first quarter financial results for the period ending March 31, 2001. Revenues for the three months increased 27% to a record $1.4 million as compared to $1.1 million for the first three months in 2000.
For more information about the financial report, visit www.calypte.com.
The CDC at a Crossroads: Budget Cuts, Public Health, and the Growing Threat of Infectious Diseases
March 12th 2025Budget cuts to the CDC threaten disease surveillance, outbreak response, and public health programs, increasing risks from measles, avian flu, and future pandemics while straining health care infrastructure nationwide.
Standing Up for Science: A Rally Participant’s Perspective
March 11th 2025Infection Control Today's Editorial Advisory Board member and contributing editor, Heather Stoltzfus, MPH, RN, CIC, recently joined the Stand Up for Science rally in Washington, DC. She gives a first-person perspective on the rally and the rally-goers' strong message.